Elizabeth H. Kelley

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Elizabeth H. Kelley is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicinal chemistry, and enzyme inhibition.

ORCID

Publications per year

2015–2023

Publications

Identification of GDC-1971 (RLY-1971), a SHP2 Inhibitor Designed for the Treatment of Solid Tumors

Alexander M. Taylor, Bret R. Williams, Fabrizio Giordanetto et al. · Journal of Medicinal Chemistry · 2023 · 43 citations · Full text

Medicine, Oncology, Pharmacology +16

Discovery of 1-(1<i>H</i>-Pyrazolo[4,3-<i>c</i>]pyridin-6-yl)urea Inhibitors of Extracellular Signal-Regulated Kinase (ERK) for the Treatment of Cancers

Jongwon Lim, Elizabeth H. Kelley, Joey L. Methot et al. · Journal of Medicinal Chemistry · 2016 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +13

Potent benzoazepinone γ-secretase modulators with improved bioavailability

Joey L. Methot, Christian Fischer, Chaomin Li et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 13 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

1–3 of 3